Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

withdrawn125%
unknown125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma

NCT02842710
completed

Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB

NCT02838641
completednot_applicable

Chepetsa TB - Reducing TB Among HIV-Infected Malawians

NCT01450085
unknownnot_applicable

Role of Genexpert in Extra Pulmonary Tuberculosis

NCT03173261

Clinical Trials (4)

Showing 4 of 4 trials
NCT02842710Not Applicable

Staphylococcus Aureus Resistant to Methicillin (MRSA) Screening in Trauma

Withdrawn
NCT02838641

Application of GeneXpert on Bronchoscopic Samples for Patients Suspicious of TB

Completed
NCT01450085Not Applicable

Chepetsa TB - Reducing TB Among HIV-Infected Malawians

Completed
NCT03173261Not Applicable

Role of Genexpert in Extra Pulmonary Tuberculosis

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4